Intraventricular Hemorrhage in Very Preterm Infants: A Comprehensive Review

Vianney Gilard1,2, Abdellah Tebani2, Soumeya Bekri2,3

  • 1Department of Pediatric Neurosurgery, Rouen University Hospital, 76000 Rouen, France.

Insights

Germinal matrix-intraventricular-intraparenchymal hemorrhage (GMH-IVH-IPH) affects very preterm infants, often leading to severe complications. Research highlights developmental immaturity and impaired cerebral autoregulation as key causes, suggesting multiomics for better biomarker discovery.

Area of Science:

  • Neonatal neurology
  • Perinatal medicine
  • Developmental neuroscience

Background:

  • Germinal matrix-intraventricular-intraparenchymal hemorrhage (GMH-IVH-IPH) is a significant complication in very preterm infants (<32 weeks gestation).
  • Incidence remains high before 27 weeks gestation, with risks of hydrocephalus and neurodevelopmental disabilities.
  • Understanding pathogenesis is crucial for improving outcomes in this vulnerable population.

Purpose of the Study:

  • To provide a comprehensive overview of GMH-IVH-IPH.
  • To identify key areas in pathogenesis, complications, neuroprotection, and biomarkers.
  • To explore potential avenues for predictive biomarker development.

Main Methods:

  • Automated literature search of PubMed (1990-2020) using "Intraventricular hemorrhage" AND "preterm" queries.
  • Initial search yielded 1093 articles; 368 were curated and analyzed.
  • Clustering approach used to identify key research topics and themes.

Main Results:

  • Identified 12 distinct research clusters related to GMH-IVH-IPH.
  • Highlighted developmental immaturity of the germinal matrix and impaired cerebral autoregulation as primary pathogenic factors.
  • Emphasized the strong association between IVH and subsequent neurodevelopmental impairments.

Conclusions:

  • GMH-IVH-IPH pathogenesis is linked to immature germinal matrix and impaired cerebral autoregulation.
  • Further multiomics research is needed to develop predictive biomarkers for very preterm newborns.
  • Improved understanding can guide neuroprotection strategies and clinical management.